Skip to main content

02.05.2024 | Original Article

Knowledge, Attitude, and Practice Toward Medication Use During Pregnancy: A Hospital-Based Cross-Sectional Survey

verfasst von: Narayana Goruntla, Neelima Ganzi, Mallika Otturu, Sai Nikhitha Vaddi, Sree Lakshmi Mood, M. Jyothi Suchitra, Kasturi Vishwanathasetty Veerabhadrappa, Joseph Obiezu Chukwujekwu Ezeonwumelu, Sarad Pawar Naik Bukke

Erschienen in: The Journal of Obstetrics and Gynecology of India

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Medication (prescription or nonprescription) use during pregnancy is associated with a risk of harm to maternal and fetal health. Pregnant women’s knowledge, attitude, and practice (KAP) toward safe medication use can influence positive outcomes. The study aims to assess and explore the risk factors associated with KAP toward medication use during pregnancy.

Methods

An interview-based, cross-sectional survey was conducted among pregnant women attending the obstetrics and gynecology department of a secondary care referral hospital. A predesigned, validated 24-item questionnaire was used to assess the KAP toward medication use among pregnant women. A binary logistic regression analysis was used to identify factors associated with the KAP levels of pregnant women.

Results

A total of 300 pregnant women with a mean (SD) age of 24.6 (3.9) years have participated in this study. The study shows that the majority of pregnant women have good knowledge (75.33%), and a positive attitude (91.33%) toward safe medication use, but the rational practice is very low (35.00%). Factors, like advanced age, urban residence, higher education level, and healthcare job, were significantly positively associated with good knowledge and rational practice toward safe medication use during pregnancy with a P < 0.05.

Conclusion

The study concludes that pregnant women have good knowledge, and positive attitudes toward safe medication use; still there is a wide gap in transforming this knowledge and behavior into real practice. So, to address the gap identified in the practice of pregnant women, a hospital or community-based sensitization program can be conducted targeting young age, rural residents, illiterates, and non-healthcare professional groups on medication safety during pregnancy.
Literatur
1.
Zurück zum Zitat Lynch MM, Squiers LB, Kosa KM, et al. Making decisions about medication use during pregnancy: implications for communication strategies. Matern Child Health J. 2018;22(1):92–100.CrossRefPubMedPubMedCentral Lynch MM, Squiers LB, Kosa KM, et al. Making decisions about medication use during pregnancy: implications for communication strategies. Matern Child Health J. 2018;22(1):92–100.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat Mulder B, Bijlsma MJ, Schuiling-Veninga CC, et al. Risks versus benefits of medication use during pregnancy: what do women perceive? Patient Prefer Adherence. 2018;12:1–8.CrossRefPubMed Mulder B, Bijlsma MJ, Schuiling-Veninga CC, et al. Risks versus benefits of medication use during pregnancy: what do women perceive? Patient Prefer Adherence. 2018;12:1–8.CrossRefPubMed
7.
Zurück zum Zitat Bolz M, Körber S, Reimer T, et al. The treatment of illnesses arising in pregnancy. Dtsch Arztebl Int. 2017;114(37):616–26.PubMedPubMedCentral Bolz M, Körber S, Reimer T, et al. The treatment of illnesses arising in pregnancy. Dtsch Arztebl Int. 2017;114(37):616–26.PubMedPubMedCentral
9.
Zurück zum Zitat Atmadani RN, Nkoka O, Yunita SL, et al. Self-medication and knowledge among pregnant women attending primary healthcare services in Malang, Indonesia: a cross-sectional study. BMC Pregnancy Childbirth [Internet]. 2020 [cited 2023 Mar 8];20(1):42. https://doi.org/10.1186/s12884-020-2736-2 Atmadani RN, Nkoka O, Yunita SL, et al. Self-medication and knowledge among pregnant women attending primary healthcare services in Malang, Indonesia: a cross-sectional study. BMC Pregnancy Childbirth [Internet]. 2020 [cited 2023 Mar 8];20(1):42. https://​doi.​org/​10.​1186/​s12884-020-2736-2
10.
Zurück zum Zitat Zou W, Xie S, Liang C, et al. Medication use during pregnancy and birth defects in Hunan province, China, during 2016–2019: a cross-sectional study. Medicine (Baltimore). 2022;101(40): e30907.CrossRefPubMed Zou W, Xie S, Liang C, et al. Medication use during pregnancy and birth defects in Hunan province, China, during 2016–2019: a cross-sectional study. Medicine (Baltimore). 2022;101(40): e30907.CrossRefPubMed
11.
Zurück zum Zitat Alema NM, Semagn G, Melesse S, et al. Patterns and determinants of prescribed drug use among pregnant women in Adigrat general hospital, northern Ethiopia: a cross-sectional study. BMC Pregnancy Childbirth [Internet]. 2020 [cited 2023 Mar 8];20(1):624. https://doi.org/10.1186/s12884-020-03327-7 Alema NM, Semagn G, Melesse S, et al. Patterns and determinants of prescribed drug use among pregnant women in Adigrat general hospital, northern Ethiopia: a cross-sectional study. BMC Pregnancy Childbirth [Internet]. 2020 [cited 2023 Mar 8];20(1):624. https://​doi.​org/​10.​1186/​s12884-020-03327-7
14.
Zurück zum Zitat Wolgast E, Lindh‐Åstrand L, Lilliecreutz C. Women’s perceptions of medication use during pregnancy and breastfeeding—A Swedish cross‐sectional questionnaire study. Acta Obstet Gynecol Scand [Internet]. 2019 [cited 2023 Mar 8];98(7):856–64. https://doi.org/10.1111/aogs.13570 Wolgast E, Lindh‐Åstrand L, Lilliecreutz C. Women’s perceptions of medication use during pregnancy and breastfeeding—A Swedish cross‐sectional questionnaire study. Acta Obstet Gynecol Scand [Internet]. 2019 [cited 2023 Mar 8];98(7):856–64. https://​doi.​org/​10.​1111/​aogs.​13570
19.
Zurück zum Zitat Twigg MJ, Lupattelli A, Nordeng H. Women’s beliefs about medication use during their pregnancy: a UK perspective. Int J Clin Pharm. 2016;38(4):968–76.CrossRefPubMedPubMedCentral Twigg MJ, Lupattelli A, Nordeng H. Women’s beliefs about medication use during their pregnancy: a UK perspective. Int J Clin Pharm. 2016;38(4):968–76.CrossRefPubMedPubMedCentral
23.
24.
Zurück zum Zitat Sawicki E, Stewart K, Wong S, Leung L, Paul E, George J. Medication use for chronic health conditions by pregnant women attending an Australian maternity hospital. Aust N Z J Obstet Gynaecol. 2011;51(4):333–8.CrossRefPubMed Sawicki E, Stewart K, Wong S, Leung L, Paul E, George J. Medication use for chronic health conditions by pregnant women attending an Australian maternity hospital. Aust N Z J Obstet Gynaecol. 2011;51(4):333–8.CrossRefPubMed
25.
26.
Zurück zum Zitat Cleary BJ, Butt H, Strawbridge JD, Gallagher PJ, Fahey T, Murphy DJ. Medication use in early pregnancy-prevalence and determinants of use in a prospective cohort of women. Pharmacoepidemiol Drug Saf. 2010;19(4):408–17.CrossRefPubMed Cleary BJ, Butt H, Strawbridge JD, Gallagher PJ, Fahey T, Murphy DJ. Medication use in early pregnancy-prevalence and determinants of use in a prospective cohort of women. Pharmacoepidemiol Drug Saf. 2010;19(4):408–17.CrossRefPubMed
27.
Zurück zum Zitat Verstappen GM, Smolders EJ, Munster JM, et al. Prevalence and predictors of over-the-counter medication use among pregnant women: a cross-sectional study in the Netherlands. BMC Public Health. 2013;2(13):185.CrossRef Verstappen GM, Smolders EJ, Munster JM, et al. Prevalence and predictors of over-the-counter medication use among pregnant women: a cross-sectional study in the Netherlands. BMC Public Health. 2013;2(13):185.CrossRef
28.
Zurück zum Zitat Dillon P, O’Brien KK, McDonnell R, et al. Prevalence of prescribing in pregnancy using the Irish primary care research network: a pilot study. BMC Pregnancy Childbirth. 2015;26(15):67.CrossRef Dillon P, O’Brien KK, McDonnell R, et al. Prevalence of prescribing in pregnancy using the Irish primary care research network: a pilot study. BMC Pregnancy Childbirth. 2015;26(15):67.CrossRef
29.
Zurück zum Zitat Mitchell AA, Gilboa SM, Werler MM, et al. Medication use during pregnancy, with particular focus on prescription drugs: 1976–2008. Am J Obstet Gynecol. 2011;205(1):51.e1-8.CrossRefPubMed Mitchell AA, Gilboa SM, Werler MM, et al. Medication use during pregnancy, with particular focus on prescription drugs: 1976–2008. Am J Obstet Gynecol. 2011;205(1):51.e1-8.CrossRefPubMed
30.
Zurück zum Zitat Coomarasamy A, Williams H, Truchanowicz E, et al. A randomized trial of progesterone in women with recurrent miscarriages. N Engl J Med. 2015;373(22):2141–8.CrossRefPubMed Coomarasamy A, Williams H, Truchanowicz E, et al. A randomized trial of progesterone in women with recurrent miscarriages. N Engl J Med. 2015;373(22):2141–8.CrossRefPubMed
33.
Zurück zum Zitat Bruno LO, Simoes RS, de Jesus SM, et al. Pregnancy and herbal medicines: an unnecessary risk for women’s health-a narrative review. Phytother Res. 2018;32(5):796–810.CrossRefPubMed Bruno LO, Simoes RS, de Jesus SM, et al. Pregnancy and herbal medicines: an unnecessary risk for women’s health-a narrative review. Phytother Res. 2018;32(5):796–810.CrossRefPubMed
34.
Zurück zum Zitat Ukoha WC, Mtshali NG. Perceptions and practice of preconception care by healthcare workers and high-risk women in South Africa: a qualitative study. Healthcare (Basel). 2021;9(11):1552.CrossRefPubMed Ukoha WC, Mtshali NG. Perceptions and practice of preconception care by healthcare workers and high-risk women in South Africa: a qualitative study. Healthcare (Basel). 2021;9(11):1552.CrossRefPubMed
Metadaten
Titel
Knowledge, Attitude, and Practice Toward Medication Use During Pregnancy: A Hospital-Based Cross-Sectional Survey
verfasst von
Narayana Goruntla
Neelima Ganzi
Mallika Otturu
Sai Nikhitha Vaddi
Sree Lakshmi Mood
M. Jyothi Suchitra
Kasturi Vishwanathasetty Veerabhadrappa
Joseph Obiezu Chukwujekwu Ezeonwumelu
Sarad Pawar Naik Bukke
Publikationsdatum
02.05.2024
Verlag
Springer India
Erschienen in
The Journal of Obstetrics and Gynecology of India
Print ISSN: 0971-9202
Elektronische ISSN: 0975-6434
DOI
https://doi.org/10.1007/s13224-024-01984-8

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.